She was destined to get early Alzheimer's, but didn't - STAT

She was destined to get early Alzheimer's, but didn't - STAT

More reads

• Aveo's cancer drug runs into a skeptical FDA. (BioPharma Dive)
• After an unprecedented death, FDA offers few hints for the future of its strategy on fecal transplants. (STAT Plus)
• Obscure model puts a price on good health — and drives down drug costs. (Wall Street Journal)
• She was destined to get early Alzheimer’s, but didn’t. Did a rare mutation protect her? (STAT)